At the protein level, immunohistochemical analysis reveals that GPC3 expression is reduced exclusively in breast and lung adenocarcinoma tissues when juxtaposed with normal tissue, while it exhibits heightened expression in various cancer types, including HCC and melanomas (as detailed in Table 1). Here, GPC3 is linked to cancer.